Skip to main content
. 2022 Jan 11;19(2):759. doi: 10.3390/ijerph19020759

Table 2.

Summary of lesions detected in the present study.

No. Age Breast Composition
(BI-RADS)
BI-RADS Category Follow Up
DBT
(BI-RADS)
CONCLUSION
(BIOPSY/FOLLOW UP)
DBT DBT + USG MRI
1. 72 b 4 4 4 N/A ILC
2. 56 b 5 5 5 N/A IDC
3. 56 b 1 1 5 N/A IDC
4. 65 c 4 5 5 N/A IDC
5. 65 c 1 1 2 1 Stable lesion
6. 65 c 1 1 2 1 Stable lesion
7. 65 c 1 1 2 1 Stable lesion
8. 65 c 3 2 2 2 Benign breast tissue
9. 58 c 1 2 2 1 Stable lesion
10. 58 c 1 2 2 1 Stable lesion
11. 58 c 1 1 2 1 Fibroglandular tissue
12. 58 c 3 2 2 2 Scar
13. 58 c 4 4 2 2 Radiotherapy changes
14. 60 c 2 2 2 2 Stable lesion
15. 54 a 4 5 5 N/A IDC
16. 78 c 1 3 4 N/A Benign breast tissue
17. 42 c 4 4 4 N/A Benign breast tissue
18. 36 d 5 5 5 N/A IDC
19. 36 d 1 2 3 N/A Benign breast tissue
20. 40 c 4 5 5 N/A ILC
21. 65 c 5 5 5 N/A ILC
22. 65 c 1 1 2 1 Resolved
23. 42 c 2 2 2 N/A Fibroadenoma
24. 46 c 4 5 5 N/A ILC

N/A = not available, IDC = invasive ductal carcinoma, ILC = invasive lobular carcinoma.